Tissue banking Market by Equipment Type (Cryopreservation systems, Labeling and Coding Equipment, Thawing Equipment, Quality Control Equipment, Alarming and Monitoring Systems), by Application (Clinical/Therapeutic, Medical Research, Cosmetics), By Tissue Type (Heart Valves, Cornea & Bone, Skin, Brain & Spinal Cord, Cord Tissues) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The Tissue Banking Market Will Expand During the Forecast Period

The global tissue banking market is expanding rapidly; it was worth $1,656.7 million in 2017 and is expected to be worth $3,674.5 million by 2026. Globally expanding cardiovascular procedures, as well as the use of advanced equipment types for excessive storage and preservation of human cells and tissues, are driving the overall market growth.

Advancement in the field of biospecimen science and biorepository is growing significantly. In the developed regions, new product launches with embedded software and robotic systems for automatic storage and preservation management are adopted software, and robotic systems for automatic storage and preservation management are adopted. Higher usage of cold storage and freezers on a global scale is generating maximum revenue share; these systems are well-equipped with temperature chart recorders, digital temperature displays, and microprocessor controllers.

Moreover, demand for regenerative medicines, organ transplantations, and cellular therapies for cord tissue is gaining traction during the forecast period. Additionally, rising medical tourism in developing economies, growing healthcare expenditure, the adoption of advanced equipment for the preservation of cells, and favorable reimbursement and insurance policies fuel the demand for the tissue banking market globally.

However, the high cost of tissue storage equipment and preservation, as well as bioethical issues, are liable for limiting the growth of the tissue banking market globally.

Market Synopsis

The cryopreservation systems equipment type segment is expected to register higher growth by the end of 2026.

The wide range of equipment types in the market incorporates experts to meet the fluctuating demand for regenerative medicines and human cells for storage and preservation. Top equipment manufacturers have expanded their products in the overseas market; they are more focused on reinforcing their geological presence to acquire a larger client base. For instance, in June 2017, Bluechiip Limited (Australia) dispatched its order for Bluechiip Buttons, cryo boxes, and readers as per the agreement with Labcon (USA). Also, in April 2018, Allele Biotechnology & Pharmaceuticals Inc. received a tissue bank license from the California Department of Public Health. In March 2016, Panasonic Healthcare launched a top-end model of the MCO-170M Ideal (multi-gas incubator) for numerous cell culture requirements that encompass CO2 and above-ambient oxygen control while processing.

Increasing Applications in the Clinical/Therapeutic Segment to Witness a Significant CAGR

Expanding interest in tissue transplantation for the treatment of cancer and chronic diseases are remarkable variables expected for the growth and development of the market. Around 500,000 individuals in the U.S. are assisted with a transplant every year. The growing prevalence of cardiovascular diseases in Europe, India, and China is a major factor in expanding the growth of the clinical and therapeutic application segment.

The rise in neurosurgical applications and the usage of skin and fresher organic membranes for wound treatment is gaining traction. A noteworthy development in the preservation and storage of tissues, inferable from immense progress in preliminary clinical studies, medical research, and biopharmaceutical organizations, has supported the administration of the tissue banking market.

The heart valve segment is expected to register higher growth by the end of 2026.

Overall demand for tissues (heart valves, skin, and cord tissues) in biobanks, hospitals, and research and academic institutes is expected to grow at a reasonably healthy rate. Moreover, changing consumer attitudes towards cellular therapies, organ transplants, blood transfusions, regenerative medicines, and vaccines, along with increasing procedures for the treatment of chronic diseases and cancer via utilizing various tissues, are generating the maximum share during the forecast period.

In addition, the heart valve in the tissue type segment is generating maximum revenue growth due to the growing prevalence of cardiovascular diseases and obesity globally. For instance, in 2017, as indicated by the WHO report, more than 17 million people died due to cardiovascular diseases worldwide. Moreover, cord tissue banking demand would surge during the forecast period due to growing awareness about cord blood storage and tissue stem cells for therapeutic applications in the treatment of heart diseases, diabetes, Parkinson's disease, cancer, and others.

North America has a dominant position due to its rising population, new product launches, and the presence of top players.

North America contributes the maximum revenue share in the overall growth of the tissue banking market, which can be attributed to the aging population and rising prevalence of cancer, heart attacks, skin diseases, and other lifestyle diseases. Higher adoption of branded and costly equipment, along with advanced services such as high storage and preservation, screening, processing, and serological and microbial testing, is growing at a significant pace. Major factors contributing to the growth include increasing awareness and programs held by top-trained and skilled professionals, higher patient safety, and the presence of top-key manufacturers in the U.S.

A few external factors enhancing the overall tissue banking industry include the high demand for regenerative medicines and human cells globally. Also, increased spending on biobanking technology, advancements in cryopreservation techniques, and cellular therapy are gaining traction during the forecast period. Increasing partnerships, growing medical tourism, and demand for advanced equipment are on the rise. However, in low-income nations such as South Africa, Asia, and Latin America, the availability of advanced systems and services is limited. A lack of physicians, a shaky supply chain, limited treatment accessibility, and high costs are limiting the market's overall growth.

The dominance of multinational manufacturers with strong equipment-type portfolios in the developed regions

Major players in the tissue banking market are Beckman Coulter, Inc.; BioLife Solutions, Inc.; Thermo Fisher Scientific Inc., KGaA; Brooks Automation, Inc.; Bluechiip Limited; VWR Corporation; PHC Corporation; Custom Biogenic Systems, Inc.; Merck; Hamilton Company; Biostorage Technologies, Inc.; and others. Top manufacturers are implementing growth strategies along with new technology assessments in advanced equipment models, new product launches, and mergers and acquisitions with medical technology companies. For instance, in July 2018, PHC Corporation presented the brand new VIP ECO Series 1 (85°C ultra-low temperature freezer) using natural refrigerants 2 in Japan. In February 2018, BioLife Solutions, Inc. completed an OEM agreement with MilliporeSigma to supply its HypoThermosol cell storage and CryoStor cell freeze media. Also, in July 2017, under the asset acquisition agreement with Cesca Therapeutics Inc., the cell processing systems of SynGen Inc.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

The current report also includes qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities, which provide a complete picture of the overall tissue banking market. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, equipment type portfolios, and business strengths.

Key questions are answered in this report.

  • What are the current market trends and dynamics in the tissue banking market, and what are the valuable opportunities for emerging players?
  • What is the market positioning of the major market players?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which tissue type holds a larger market share and why?
  • What is the impact of high equipment costs on the tissue banking market?
  • Are low- and middle-income economies investing in the tissue banking market?
  • What are the market trends and dynamics in emerging markets such as Japan, Latin America, the Middle East, and Africa?

Frequently Asked Questions:

The market for Tissue banking is expected to reach US$ 3,674.5 Mn in 2026.

The Tissue banking market is expected to see significant CAGR growth over the coming years,at XX%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Thermo Fisher Scientific Inc.KGaA,Brooks Automation, Inc.,VWR Corporation,BioLife Solutions, Inc.,PHC Corporation are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Sep 2018
Category:  Medical Devices
Report ID:   59352
Report Format:   PDF
Pages:   120
Rating:    4.4 (49)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support